About   Help   FAQ
Symbol
Name
ID
Ins2
insulin II
MGI:96573
Phenotype annotations related to homeostasis/metabolism
*Aspects of the system are reported to show a normal phenotype.
Darker colors indicate more annotations
Human Phenotypes
Decreased level of 1,5 anhydroglucitol in serum
Reduced C-peptide level
Elevated circulating hepatic transaminase concentration
Hyperglycemia
Diabetes mellitus
Diabetic ketoacidosis
Maturity-onset diabetes of the young
Type I diabetes mellitus
Type II diabetes mellitus
Insulin resistance
Ketoacidosis
Disease(s) Associated with INS
maturity-onset diabetes of the young type 10
pancreatic cancer
permanent neonatal diabetes mellitus
type 1 diabetes mellitus
type 1 diabetes mellitus 2
type 2 diabetes mellitus

Mouse Phenotypes
homeostasis/metabolism phenotype
decreased insulin secretion
increased insulin secretion
abnormal homeostasis
increased circulating glucose level
hyperglycemia
decreased circulating insulin level
decreased circulating leptin level
decreased circulating triglyceride level
increased energy expenditure
increased carbon dioxide production
increased oxygen consumption
decreased respiratory quotient
abnormal glucose homeostasis
impaired glucose tolerance
increased urine glucose level
increased insulin sensitivity
insulin resistance
decreased liver triglyceride level
decreased skeletal muscle triglyceride level
albuminuria
Availability Mouse Genotype
Ins2Akita/Ins2Akita
Ins2C95S/Ins2C95S
Ins2tm1(cre/ERT2)Kcmm/Ins2tm1(cre/ERT2)Kcmm *
Ins2tm1Jja/Ins2tm1Jja
Ins2tm1Rll/Ins2tm1Rll *
Ins1tm1.1(cre)Thor/Ins1+ *
Ins2Akita/Ins2+ *
Ins2C95S/Ins2+
Ins2em#Arak/Ins2+
Ins2Akita/?

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory